{"id":"pentostam","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL4444260","moleculeType":"Unknown","molecularWeight":"903.98"},"aliases":["Pentavalent antimonials"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-28T04:02:48.869Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Leishmaniasis","diseaseId":"leishmaniasis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07496944","phase":"NA","title":"Effects of Blood Flow Restriction and Small-Sided Games on Soccer Passing and Dribbling Stability Under Fatigue","status":"COMPLETED","sponsor":"Beijing Sport University","startDate":"2026-01-20","conditions":"Athletic Performance","enrollment":40},{"nctId":"NCT07463040","phase":"PHASE3","title":"Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL)","status":"NOT_YET_RECRUITING","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2027-01-01","conditions":"Cutaneous Leihmaniasis","enrollment":900},{"nctId":"NCT05957978","phase":"PHASE2","title":"LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","startDate":"2024-03-29","conditions":"Primary Visceral Leishmaniasis","enrollment":52},{"nctId":"NCT06798402","phase":"PHASE2","title":"Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate","status":"RECRUITING","sponsor":"Al-Mustafa University College","startDate":"2025-02-07","conditions":"Cutaneous Leishmaniasis","enrollment":80},{"nctId":"NCT04342715","phase":"","title":"A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of York","startDate":"2022-05-22","conditions":"Visceral Leishmaniasis","enrollment":216},{"nctId":"NCT04699383","phase":"","title":"Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia","status":"COMPLETED","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2021-02-15","conditions":"Cutaneous Leishmaniasis","enrollment":105},{"nctId":"NCT03129646","phase":"PHASE3","title":"Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","startDate":"2018-01-24","conditions":"Visceral Leishmaniasis","enrollment":439},{"nctId":"NCT00508963","phase":"","title":"Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis","status":"NO_LONGER_AVAILABLE","sponsor":"University of California, San Francisco","startDate":"","conditions":"Leishmaniasis, Cutaneous, Leishmaniasis, Mucocutaneous","enrollment":""},{"nctId":"NCT05708625","phase":"PHASE3","title":"Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis","status":"UNKNOWN","sponsor":"Zagazig University","startDate":"2022-01-01","conditions":"Leishmaniasis, Cutaneous","enrollment":136},{"nctId":"NCT04906031","phase":"PHASE2","title":"Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Jinan University","startDate":"2020-06-01","conditions":"Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myeloid Malignancy","enrollment":5},{"nctId":"NCT04884074","phase":"NA","title":"Effect of Routine Anterior Crural Repair in De-Novo Gastroesophageal Reflux After Laparoscopic Sleeve Gastrectomy","status":"UNKNOWN","sponsor":"Chinese University of Hong Kong","startDate":"2021-05-01","conditions":"Obesity, Gastro Esophageal Reflux Disease","enrollment":50},{"nctId":"NCT00662012","phase":"PHASE2","title":"Sodium Stibogluconate Treatment of Leishmaniasis","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2002-06","conditions":"Leishmaniasis","enrollment":414},{"nctId":"NCT00498979","phase":"PHASE1","title":"Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2007-05","conditions":"Stage IV Melanoma","enrollment":22},{"nctId":"NCT00884377","phase":"PHASE2","title":"Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2004-02","conditions":"Cutaneous Leishmaniasis","enrollment":56},{"nctId":"NCT00657618","phase":"PHASE1, PHASE2","title":"Use of Sodium Stibogluconate as a Treatment for Leishmaniasis","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2004-10","conditions":"Leishmaniasis","enrollment":77},{"nctId":"NCT00629200","phase":"PHASE1","title":"Sodium Stibogluconate With Interferon Alpha-2b for Patients With Advanced Malignancies","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-09-13","conditions":"Advanced Cancer, Solid Tumors","enrollment":33},{"nctId":"NCT00311558","phase":"PHASE1","title":"Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2005-10","conditions":"Cancer","enrollment":18},{"nctId":"NCT01067443","phase":"PHASE2","title":"Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","startDate":"2010-03","conditions":"Primary Visceral Leishmaniasis","enrollment":151},{"nctId":"NCT03009422","phase":"NA","title":"Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis.","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2014-11","conditions":"Leishmaniasis","enrollment":20},{"nctId":"NCT00255567","phase":"PHASE3","title":"Efficacy/Safety of Sodium Stibogluconate (SSG) Versus Paromomycin (PM) and SSG/PM Combination to Treat V Leishmaniasis","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","startDate":"2004-11","conditions":"Visceral Leishmaniasis","enrollment":1142},{"nctId":"NCT02281669","phase":"","title":"Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2014-11","conditions":"Cutaneous Leishmaniasis","enrollment":100},{"nctId":"NCT01011309","phase":"PHASE2","title":"A Study of the Efficacy and Safety of the LEISH-F2 + MPL-SE Vaccine for Treatment of Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"Access to Advanced Health Institute (AAHI)","startDate":"2009-10","conditions":"Cutaneous Leishmaniasis","enrollment":45},{"nctId":"NCT01009502","phase":"PHASE1","title":"Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome","status":"TERMINATED","sponsor":"Northwestern University","startDate":"2009-07","conditions":"Myelodysplastic Syndromes","enrollment":1},{"nctId":"NCT01661296","phase":"PHASE4","title":"Efficacy of Radio-frequency Induced Heat (RFH)Therapy in Treatment of Cutaneous Leishmaniasis in India","status":"COMPLETED","sponsor":"Sarder Patel Medical College","startDate":"2009-08","conditions":"Cutaneous Leishmaniasis","enrollment":100},{"nctId":"NCT00996463","phase":"PHASE2","title":"Rationales for Wound Care Management in Old World Cutaneous Leishmaniasis Patients","status":"COMPLETED","sponsor":"Waisenmedizin e. V. Promoting Access to Essential Medicine","startDate":"2010-01","conditions":"Wound Healing","enrollment":63}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_2","status":"active","brandName":"Pentostam","genericName":"Pentostam","companyName":"Sheba Medical Center","companyId":"sheba-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pentostam, also known as sodium stibogluconate, is a medication used to treat leishmaniasis, including cutaneous, visceral, and mucosal types. It is administered by injection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}